Antibody Stabilizers for Complement Engagement and Neoplasm Targeting (ASCENT): stabilizers of C3 convertase for cancer cell targeting
Research Project | 01.12.2026 - 31.05.2028
|
01.12.2026
- 31.05.2028
Funding
Antibody Stabilizers for Complement Engagement and Neoplasm Targeting (ASCENT): stabilizers of C3 convertase for cancer cell targeting
Innosuisse Projekt (GrantsTool), 12.2026-05.2028 (18)
PI : Mac Sweeney, Aengus,Ricklin, Daniel.
Members (2)
Aengus Mac Sweeney
Principal Investigator
